Combined Antithrombotic Treatment With Aspirin and Clopidogrel for Patients With Capsular Warning Syndrome A Case Report

Asil, TalipIr, NasifKaraduman, FatihCagli, BekirTuncel, Sedat2024-06-122024-06-1220121074-7931https://doi.org/10.1097/NRL.0b013e318247b9a5https://hdl.handle.net/20.500.14551/19502Capsular warning syndrome is characterized by recurrent transient ischemic attacks and is caused by microthrombosis or hypoperfusion of small-sized vessels. The pathophysiological basis of this syndrome is not well understood and currently a consensus has not been reached on its optimal treatment. In this study, we present 2 cases with favorable clinical outcomes after combined antithrombotic treatment with loading doses of clopidogrel and aspirin.en10.1097/NRL.0b013e318247b9a5info:eu-repo/semantics/closedAccessCapsular Warning SyndromeAntithromboticsClopidogrelCombined Antithrombotic Treatment With Aspirin and Clopidogrel for Patients With Capsular Warning Syndrome A Case ReportArticle1826869Q3WOS:0003009082000032-s2.0-8485811061122367831Q3